Abstract
Understanding the pathophysiology of the various clinical forms of leishmaniasis found in Brazil requires a deep phenotyping of patient responses that operate at the site of infection. Aiming the phenotyping, there is an ongoing molecular pathology project (with MRC funding) including data sharing through a digital pathology platform. In this project, new multiplex immunohistochemistry a…